实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
4期
551-553
,共3页
黄红艺%莫云%何冰%刘杨桦%张团英%张凤兰
黃紅藝%莫雲%何冰%劉楊樺%張糰英%張鳳蘭
황홍예%막운%하빙%류양화%장단영%장봉란
多囊卵巢综合征%胰岛素抵抗%不孕%Apelin
多囊卵巢綜閤徵%胰島素牴抗%不孕%Apelin
다낭란소종합정%이도소저항%불잉%Apelin
Polycystic ovary syndrome%Insulin resistance%Infertility%Apelin
目的:研究多囊卵巢综合征(PCOS)不孕患者血清 Apelin 水平的变化及其与胰岛素抵抗(IR)的关系。方法:选择2011年1月至2012年6月间首次来我院就诊的98例PCOS不孕患者及72例非PCOS不孕患者,分别分为PCOS组和非PCOS组。分别比较两组患者的体重指数(BMI)、血清Apelin、血糖、胰岛素、稳态模型胰岛素抵抗指数(HOMA-IR)间的相互关系。血清Apelin采用ELISA法测定,空腹血浆葡萄糖(FPG)采用葡萄糖氧化酶法测定,空腹胰岛素(FIns)采用化学发光法测定。结果:PCOS 组血清Apelin 水平(μg/L)明显高于非PCOS组(3.28±1.24 vs.1.94±0.78, P<0.05)。 PCOS 组的HOMA-IR 高于非PCOS 组(3.84±1.23 vs.2.14±0.77, P<0.05); Person 相关分析表明, PCOS 组血清 Apelin 水平与 HOMA-IR 相关(r=0.65, P<0.01)。结论:PCOS不孕患者血清Apelin水平升高,并且其升高与IR 密切相关。提示Apelin可能参与PCOS不孕患者IR的发生发展。
目的:研究多囊卵巢綜閤徵(PCOS)不孕患者血清 Apelin 水平的變化及其與胰島素牴抗(IR)的關繫。方法:選擇2011年1月至2012年6月間首次來我院就診的98例PCOS不孕患者及72例非PCOS不孕患者,分彆分為PCOS組和非PCOS組。分彆比較兩組患者的體重指數(BMI)、血清Apelin、血糖、胰島素、穩態模型胰島素牴抗指數(HOMA-IR)間的相互關繫。血清Apelin採用ELISA法測定,空腹血漿葡萄糖(FPG)採用葡萄糖氧化酶法測定,空腹胰島素(FIns)採用化學髮光法測定。結果:PCOS 組血清Apelin 水平(μg/L)明顯高于非PCOS組(3.28±1.24 vs.1.94±0.78, P<0.05)。 PCOS 組的HOMA-IR 高于非PCOS 組(3.84±1.23 vs.2.14±0.77, P<0.05); Person 相關分析錶明, PCOS 組血清 Apelin 水平與 HOMA-IR 相關(r=0.65, P<0.01)。結論:PCOS不孕患者血清Apelin水平升高,併且其升高與IR 密切相關。提示Apelin可能參與PCOS不孕患者IR的髮生髮展。
목적:연구다낭란소종합정(PCOS)불잉환자혈청 Apelin 수평적변화급기여이도소저항(IR)적관계。방법:선택2011년1월지2012년6월간수차래아원취진적98례PCOS불잉환자급72례비PCOS불잉환자,분별분위PCOS조화비PCOS조。분별비교량조환자적체중지수(BMI)、혈청Apelin、혈당、이도소、은태모형이도소저항지수(HOMA-IR)간적상호관계。혈청Apelin채용ELISA법측정,공복혈장포도당(FPG)채용포도당양화매법측정,공복이도소(FIns)채용화학발광법측정。결과:PCOS 조혈청Apelin 수평(μg/L)명현고우비PCOS조(3.28±1.24 vs.1.94±0.78, P<0.05)。 PCOS 조적HOMA-IR 고우비PCOS 조(3.84±1.23 vs.2.14±0.77, P<0.05); Person 상관분석표명, PCOS 조혈청 Apelin 수평여 HOMA-IR 상관(r=0.65, P<0.01)。결론:PCOS불잉환자혈청Apelin수평승고,병차기승고여IR 밀절상관。제시Apelin가능삼여PCOS불잉환자IR적발생발전。
Objective To explore the change of serum Apelin level and its relationship with insulin resistance (IR) in infertility patients with polycystic ovarian syndrome (PCOS). Methods Ninety-eight infertility patients with PCOS (PCOS group) and 72 infertility patients without PCOS (non-PCOS group) visiting our hospital for the first time from January 2011 to June 2012 were selected. The BMI , serum Apelin level (detected by ELISA), fasting blood glucose (FPG, detected by glucose oxidase method), fasting insulin (Fins, detected by chemiluminescence), and homeostasis model assessment of insulin resistance index (HOMA-IR) of the two groups were detected. Results The serum Apelin level and HOMA-IR in PCOS patients were higher than those in non-PCOS patients (3.28 ± 1.24 vs. 1.94 ± 0.78, P < 0.05; 3.84 ± 1.23 vs. 2.14 ± 0.77,P < 0.05). Pearson correlation analysis showed that serum Apelin level was positively correlated with HOMA-IR in PCOS patients (r=0.65, P<0.01). Conclusions The serum Apelin level in infertility patients with PCOS increased evidently, and was positively correlated with HOMA-IR; which indicated that Apelin may involve in the development of IR in infertility patients with PCOS.